Free Trial

Smith & Nephew SNATS (SNN) Competitors

Smith & Nephew SNATS logo
$30.16 -0.44 (-1.44%)
Closing price 03:59 PM Eastern
Extended Trading
$30.16 +0.00 (+0.02%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, GKOS, NARI, IRTC, and TMDX

Should you be buying Smith & Nephew SNATS stock or one of its competitors? The main competitors of Smith & Nephew SNATS include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry.

Smith & Nephew SNATS vs. Its Competitors

GE HealthCare Technologies (NASDAQ:GEHC) and Smith & Nephew SNATS (NYSE:SNN) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

GE HealthCare Technologies has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, Smith & Nephew SNATS has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500.

GE HealthCare Technologies presently has a consensus price target of $88.27, suggesting a potential upside of 15.97%. Smith & Nephew SNATS has a consensus price target of $28.00, suggesting a potential downside of 7.16%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, equities analysts clearly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83
Smith & Nephew SNATS
0 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays an annual dividend of $0.89 per share and has a dividend yield of 3.0%. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Smith & Nephew SNATS pays out 41.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

GE HealthCare Technologies has a net margin of 11.02% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 24.95% beat Smith & Nephew SNATS's return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies11.02% 24.95% 6.38%
Smith & Nephew SNATS N/A N/A N/A

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, GE HealthCare Technologies had 24 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 25 mentions for GE HealthCare Technologies and 1 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 1.28 beat Smith & Nephew SNATS's score of 1.22 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
19 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Smith & Nephew SNATS
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS. Smith & Nephew SNATS is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$19.67B1.77$1.99B$4.7516.03
Smith & Nephew SNATS$5.81B2.27$412M$2.1613.96

Summary

GE HealthCare Technologies beats Smith & Nephew SNATS on 17 of the 20 factors compared between the two stocks.

Get Smith & Nephew SNATS News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNN vs. The Competition

MetricSmith & Nephew SNATSMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$13.21B$10.24B$5.49B$20.51B
Dividend Yield2.92%2.11%5.38%3.76%
P/E Ratio13.9616.6626.2127.83
Price / Sales2.2729.93415.2037.43
Price / Cash9.7022.8736.4921.79
Price / Book2.503.648.054.55
Net Income$412M$233.36M$3.15B$984.47M
7 Day Performance0.87%1.41%1.93%3.58%
1 Month Performance3.39%3.40%4.91%6.04%
1 Year Performance22.20%-11.84%35.87%14.49%

Smith & Nephew SNATS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNN
Smith & Nephew SNATS
3.7487 of 5 stars
$30.16
-1.4%
$28.00
-7.2%
+24.8%$13.21B$5.81B13.9617,349Positive News
GEHC
GE HealthCare Technologies
4.2132 of 5 stars
$71.16
-0.2%
$88.27
+24.0%
-0.4%$32.64B$19.67B15.5053,000Positive News
Dividend Announcement
PHG
Koninklijke Philips
3.4338 of 5 stars
$22.67
+1.7%
N/A-3.5%$21.46B$19.50B52.7266,678
ZBH
Zimmer Biomet
4.8696 of 5 stars
$91.51
+0.3%
$111.53
+21.9%
-11.3%$18.05B$7.68B11.5917,000
SOLV
Solventum
0.8839 of 5 stars
$73.21
-0.5%
$80.29
+9.7%
+51.4%$12.73B$8.25B13.4722,000Positive News
Analyst Upgrade
PEN
Penumbra
4.7319 of 5 stars
$254.41
-1.0%
$302.40
+18.9%
+41.8%$9.95B$1.19B78.084,500
STVN
Stevanato Group
N/A€23.62
+1.4%
N/A+32.9%€7.15B€1.19B46.315,521Positive News
Analyst Forecast
Gap Down
GKOS
Glaukos
4.3423 of 5 stars
$96.80
-3.3%
$134.67
+39.1%
-12.6%$5.72B$383.48M-40.84780
NARI
Inari Medical
0.4704 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
IRTC
iRhythm Technologies
1.2242 of 5 stars
$150.95
+3.6%
$138.60
-8.2%
+37.1%$4.65B$591.84M0.002,000
TMDX
TransMedics Group
1.5839 of 5 stars
$127.53
+3.2%
$127.33
-0.2%
-13.4%$4.18B$441.54M90.85210Positive News

Related Companies and Tools


This page (NYSE:SNN) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners